Combining incretin-based drugs and RAAS inhibitors: more cons than pros?

Research output: Contribution to journal › Article › Academic › peer-review

10 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	684-685
Journal	LANCET DIABETES & ENDOCRINOLOGY
Volume	2
Issue number	9
DOIs	https://doi.org/10.1016/S2213-8587(14)70167-6
Publication status	Published - 2014

Access to Document

@article{04250d9ad1264998add97419ffb9ee1e,

title = "Combining incretin-based drugs and RAAS inhibitors: more cons than pros?",

author = "L. Tonneijck and M.H.A. Muskiet and M.M. Smits and {van Raalte}, D.H. and M. Diamant",

year = "2014",

doi = "https://doi.org/10.1016/S2213-8587(14)70167-6",

language = "Undefined/Unknown",

volume = "2",

pages = "684--685",

journal = "LANCET DIABETES & ENDOCRINOLOGY",

issn = "2213-8587",